Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at everolimus, cisplatin and etoposide for small cell lung cancer

Overview

Cancer types:

Lung cancer, Small cell lung cancer

Status:

Results

Phase:

Phase 1

Details

This trial looked at a drug called everolimus in combination with cisplatin and etoposide chemotherapy for small cell lung cancer that has spread.

Recruitment start: 26 April 2007

Recruitment end: 30 November 2009

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Peter Schmid

Supported by

Experimental Cancer Medicine Centre (ECMC)

Novartis

Last reviewed: 12 August 2014

CRUK internal database number: 1591

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.